Hallux Rigidus Clinical Trial
Official title:
A Prospective, Non-comparative, Multi-centre, Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus
NCT number | NCT05692687 |
Other study ID # | IN2B01 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | March 15, 2023 |
Est. completion date | November 2025 |
Verified date | May 2023 |
Source | Invibio Ltd |
Contact | Karen 2 Robson |
Phone | +447765220492 |
karen.robson[@]invibio.com | |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The clinical study involves the routine treatment of skeletally mature patients who have been diagnosed with hallux rigidus (stiffness of the first metatarso-phalangeal joint in the foot due to arthritis and degeneration of cartilage). It follows standard practice surgery to treat this condition. This type of degenerative arthritis affects the joint of the big toe (hallux) which is attached to the foot. Taking part in this research will involve collecting data of the surgery to remove damaged cartilage and fix the two bones together with screws and a plate (called the CoLink® PCR MTP Plate).
Status | Recruiting |
Enrollment | 40 |
Est. completion date | November 2025 |
Est. primary completion date | July 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Subjects aged 18 years of age or older (> 18 years) and are skeletally mature. 2. Subjects who require surgical treatment for hallux rigidus and have been evaluated as appropriate candidates for treatment with the CoLinkĀ® PCR MTP Plate by the Investigator. 3. Subjects who, in the opinion of the Investigator, are able to understand this clinical study, co-operate with the procedures and are willing to return to the hospital for all the required post-operative follow-ups. 4. Subjects who are able to give voluntary, written informed consent to participate in this clinical study and from whom consent has been obtained. Exclusion Criteria: 1. Subjects who have previously undergone MTP fusion surgery or implant arthroplasty in the foot to be treated. 2. Subjects who require bi-lateral MTP fusion surgery. 3. Subjects with evidence of tumour and/or malignant disease with resultant life expectancy of less than two years. 4. Subjects with a known allergy to the material used in the instrumentation. 5. Subjects with evidence of an active infection and/or with any condition that would compromise their participation and follow-up in this clinical study. 6. Subjects who have any conditions outlined as contraindicated in the Instructions for Use. 7. Female subjects who are pregnant or lactating. 8. Subjects who are known drug or alcohol abusers, or with a baseline opioid use greater than 30 mg of morphine equivalent/day, or with psychological disorders that could affect follow-up care or treatment outcomes. 9. Subjects who are current smokers or have stopped smoking less than 6 months ago. 10. Subjects who are currently enrolled in a clinical study. |
Country | Name | City | State |
---|---|---|---|
United States | Mississippi Sports Medicine and Orthopedic Center, | Jackson | Mississippi |
United States | University of Kansas Medical Centre | Kansas City | Kansas |
United States | South Florida Foot and Ankle Center | Lake Worth | Florida |
Lead Sponsor | Collaborator |
---|---|
Invibio Ltd | In2Bones |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Bone Fusion | Successful radiographic union: where union is defined as 'evidence of bridging' between the metatarsal bone and proximal phalanx bone by an independent imaging company. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04473196 -
The Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion
|
N/A | |
Recruiting |
NCT05555459 -
Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation
|
N/A | |
Active, not recruiting |
NCT04590313 -
Efficacy of First MTPJ Arthrodesis as a Treatment in Hallux Rigidus
|
N/A | |
Completed |
NCT02904447 -
Plantar Forces Mid-term After Hemiarthroplasty With HemiCap for Hallux Rigidus
|
N/A | |
Completed |
NCT01804491 -
Motion Analysis in Patients With Hallux Rigidus
|
N/A | |
Terminated |
NCT04103814 -
Effect of Topical CBD Cream for Degenerative Hallux Disorders
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05795127 -
Risk for Reoperation After First MTP Joint Arthrodesis
|
||
Recruiting |
NCT03133039 -
A New Type of Bioabsorbable Screw in the Hallux Valgus Surgery
|
N/A | |
Completed |
NCT05641038 -
Comparison Of The Efficiencies Of Peloid and Paraffine Treatments In Patients With Hallux Rigidus
|
N/A | |
Recruiting |
NCT06331741 -
Collagen for Treatment of Musculoskeletal Injuries
|
N/A | |
Withdrawn |
NCT05518721 -
Synthetic Cartilage Implant Versus Interposition Arthroplasty in Hallux Rigidus Treatment: A Randomized Clinical Trial
|
N/A | |
Terminated |
NCT02499575 -
Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures
|
N/A | |
Completed |
NCT01048450 -
Surgical Treatment for Hallux Rigidus
|
N/A | |
Active, not recruiting |
NCT06180408 -
Foot Spine Syndrome "RAFFET Syndrome"
|
N/A | |
Completed |
NCT01284985 -
Short Term Follow-up of Patient Implanted With the Metatarso-Phalangeal Prosthesis METIS®
|
N/A | |
Recruiting |
NCT01028469 -
Artelon Metatarsophalangeal (MTP) Spacer
|
Phase 4 | |
Recruiting |
NCT03616847 -
Comparison of Different Tourniquet Release Times in Bunion Surgery
|
N/A | |
Completed |
NCT01825356 -
Amniotic Membrane as an Adjunct Treatment for Hallux Rigidus
|
Phase 4 | |
Completed |
NCT04833608 -
Managing Pain in Patients With MTP Arthritis
|
N/A | |
Terminated |
NCT03935880 -
Surgical Treatment for Great Toe Arthritis
|
N/A |